Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker.
Miguel A Alvarez-MonMiguel Ángel OrtegaCielo García-MonteroOscar Fraile-MartinezGuillermo LaheraJorge MonserratAna M Gomez-LahozPatricio MoleroLuis Gutierrez-RojasRoberto Rodriguez-JimenezJavier QuinteroMelchor Alvarez-MonPublished in: The Journal of international medical research (2022)
The findings of this current study provide further evidence of the role pathophysiological relevance of OS and MDA in MDD. This study provides the basis for the use of MDA as a biomarker for MDD.